SPIRONOLACTONE | A217761 | ANNORA PHARMA PRIVATE LTD
Highest NADAC/Unit
$0.1759
per ea
Lowest NADAC/Unit
$0.0443
per ea
Brand NDCs
0
Generic NDCs
7
| NDC Description | NADAC/Unit | Unit | Type | Generic NADAC | Effective |
|---|---|---|---|---|---|
| 31722009601SPIRONOLACTONE 100 MG TABLET | $0.1759 | EA | Generic | — | 2026-06-17 |
| 31722009605SPIRONOLACTONE 100 MG TABLET | $0.1759 | EA | Generic | — | 2026-06-17 |
| 31722009501SPIRONOLACTONE 50 MG TABLET | $0.0875 | EA | Generic | — | 2026-06-17 |
| 31722009505SPIRONOLACTONE 50 MG TABLET | $0.0875 | EA | Generic | — | 2026-06-17 |
| 31722009405SPIRONOLACTONE 25 MG TABLET | $0.0443 | EA | Generic | — | 2026-06-17 |
| 31722009410SPIRONOLACTONE 25 MG TABLET | $0.0443 | EA | Generic | — | 2026-06-17 |
| 31722009401SPIRONOLACTONE 25 MG TABLET | $0.0443 | EA | Generic | — | 2026-06-17 |
Source: NADAC (data.medicaid.gov). Prices reflect national average acquisition costs for retail community pharmacies.
No patent or exclusivity listings for this strength.